
Congress trades
Park Ha Biological Technology Co., Ltd. (PHH)
NASDAQ · Consumer Defensive · 10 congress trades · last filed 10 years ago
About Park Ha Biological Technology Co., Ltd.
from the company's filings and listing, as of Oct 24, 2026- Exchange
- NASDAQ
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Chief executive
- Xiaoqiu Zhanglast on record
- Employees
- 17
- Listed since
- Jan 19, 2005
- Market value
- $10.0Mlast quoted Oct 27, 2025
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -
- Dividend yield
- -
Congress trades in PHH
10 disclosures of 10 on record · median 25d of the 45 allowedSince the trade: the stock's move from the trade date to the last close under this ticker (Oct 27, 2025), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Seth Moulton | Stock | Sale | $1,001 - $15,000 | -95.8%After the saleS&P 500 +255.2% · -350.9 pts vs S&P 500 | Feb 29, 2016 | Jul 5, 2016 | 127d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.5%After the saleS&P 500 +273.6% · -372.2 pts vs S&P 500 | Feb 14, 2014 | Mar 13, 2014 | 27d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.5%After the saleS&P 500 +273.1% · -371.6 pts vs S&P 500 | Feb 18, 2014 | Mar 13, 2014 | 23d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.5%After the saleS&P 500 +275.7% · -374.2 pts vs S&P 500 | Feb 19, 2014 | Mar 13, 2014 | 22d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.5%After the saleS&P 500 +273.6% · -372.1 pts vs S&P 500 | Feb 20, 2014 | Mar 13, 2014 | 21d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.5%After the saleS&P 500 +273.7% · -372.3 pts vs S&P 500 | Feb 21, 2014 | Mar 13, 2014 | 20d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.4%After the saleS&P 500 +283.9% · -382.3 pts vs S&P 500 | Jan 28, 2014 | Feb 12, 2014 | 15d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.3%After the saleS&P 500 +283.6% · -382.0 pts vs S&P 500 | Dec 16, 2013 | Jan 16, 2014 | 31d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.4%After the saleS&P 500 +285.0% · -383.4 pts vs S&P 500 | Dec 17, 2013 | Jan 16, 2014 | 30d |
| Michael T. McCaul | Stock | Sale | $1,001 - $15,000 | -98.4%After the saleS&P 500 +278.4% · -376.8 pts vs S&P 500 | Dec 18, 2013 | Jan 16, 2014 | 29d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in PHH, filterable by party, chamber, type and account.
Questions
Which members of Congress have traded PHH?
Seth Moulton and Michael T. McCaul disclosed PHH transactions in the filings shown here.
How quickly are PHH trades disclosed?
Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.
